Locoregional Stomach Cancer
Stomach Adenocarcinoma
Female, 67 years
Patient Internal ID: 500412336
ICD-10 code
C16.8 Malignant Neoplasm of Overlapping Sites of Stomach
Diagnosis (Incl. Metastases/Stage) and Year
November 2020
Stomach Adenocarcinoma T4N3(22/26)M1 R0, R0 HER2(-), MMRp
Previous Treatment
Chemotherapy (Neoadjuvant FLOT), Surgery (Total Gastrectomy).
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of ~13 months from diagnosis.
Treatment Provided
Autologous DCV (5 doses) and CIK (4 doses) over a period of 4 months.
Patient Survival/Condition and Year
Date of Review: 06/11/2023
The patient has survived for over 29 months from diagnosis. According to Tumor Board, the decision was not to prescribe Adjuvant Chemotherapy, as little response was observed during Neoadjuvant Chemotherapy. It can be concluded that the addition of Immunotherapy, together with Surgery and Chemotherapy, extended patient survival by an estimate of 16 months.
